DE69618630T2 - Methode zur in vitro-bestimmung der bioaktivität von erythropoietin - Google Patents

Methode zur in vitro-bestimmung der bioaktivität von erythropoietin

Info

Publication number
DE69618630T2
DE69618630T2 DE69618630T DE69618630T DE69618630T2 DE 69618630 T2 DE69618630 T2 DE 69618630T2 DE 69618630 T DE69618630 T DE 69618630T DE 69618630 T DE69618630 T DE 69618630T DE 69618630 T2 DE69618630 T2 DE 69618630T2
Authority
DE
Germany
Prior art keywords
epo
sample
vitro
cells
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69618630T
Other languages
English (en)
Other versions
DE69618630D1 (de
Inventor
J Lisi
K Glenn
Chi-Kwong So
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE69618630D1 publication Critical patent/DE69618630D1/de
Application granted granted Critical
Publication of DE69618630T2 publication Critical patent/DE69618630T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746Erythropoetin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69618630T 1996-09-20 1996-09-20 Methode zur in vitro-bestimmung der bioaktivität von erythropoietin Expired - Lifetime DE69618630T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/015049 WO1998012558A1 (en) 1996-09-20 1996-09-20 Methods for in vitro determination of erythropoietin bioactivity

Publications (2)

Publication Number Publication Date
DE69618630D1 DE69618630D1 (de) 2002-02-21
DE69618630T2 true DE69618630T2 (de) 2002-05-08

Family

ID=22255824

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618630T Expired - Lifetime DE69618630T2 (de) 1996-09-20 1996-09-20 Methode zur in vitro-bestimmung der bioaktivität von erythropoietin

Country Status (13)

Country Link
EP (1) EP0935752B1 (de)
JP (1) JP3764487B2 (de)
KR (1) KR100295506B1 (de)
AT (1) ATE209354T1 (de)
AU (1) AU715237B2 (de)
CA (1) CA2265989C (de)
DE (1) DE69618630T2 (de)
DK (1) DK0935752T3 (de)
ES (1) ES2168509T3 (de)
IL (1) IL129028A0 (de)
NO (1) NO321047B1 (de)
PT (1) PT935752E (de)
WO (1) WO1998012558A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73544A (en) * 1984-11-19 1988-11-15 Yissum Res Dev Co In vitro bioassay of erythropoietin in the absence of serum involving dna synthesis by erythroid precursors
AU4104889A (en) * 1988-09-07 1990-03-15 Bioclones (Pty) Ltd Purification of erythropoietin
JP2750600B2 (ja) * 1989-02-17 1998-05-13 雪印乳業株式会社 エリスロポエチンの生物活性測定方法
AU8735991A (en) * 1990-09-28 1992-04-28 Ortho Pharmaceutical Corporation Hybrid growth factors

Also Published As

Publication number Publication date
PT935752E (pt) 2002-03-28
ES2168509T3 (es) 2002-06-16
IL129028A0 (en) 2000-02-17
NO991338L (no) 1999-03-19
JP3764487B2 (ja) 2006-04-05
KR100295506B1 (ko) 2001-08-07
CA2265989A1 (en) 1998-03-26
KR20000048492A (ko) 2000-07-25
NO991338D0 (no) 1999-03-19
ATE209354T1 (de) 2001-12-15
CA2265989C (en) 2010-11-02
AU7162696A (en) 1998-04-14
JP2001500736A (ja) 2001-01-23
EP0935752B1 (de) 2001-11-21
DE69618630D1 (de) 2002-02-21
EP0935752A1 (de) 1999-08-18
DK0935752T3 (da) 2002-05-21
WO1998012558A1 (en) 1998-03-26
NO321047B1 (no) 2006-03-06
AU715237B2 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
Bellamkonda et al. Hydrogel‐based three‐dimensional matrix for neural cells
CA2244659A1 (en) Biological reactor for the cultivation of cells
ATE19895T1 (de) Stabilisierung von oxidase.
DE69834257D1 (de) Natürliche killerzelllinien und verfahren zu ihrer verwendung
DK0461166T4 (da) Fremgangsmåde til styring og/eller overvågning af biologiske processer
ATE115411T1 (de) Antikörper gegen eine zusammensetzung mit mediatoraktivität und seine verwendung in einer pharmazeutischen zusammensetzung.
DE69432540T2 (de) Verfahren zur Herstellung von Nucleinsäuren aus einer biologischen Probe bei niedrigem pH und unter Verwendung einer Säureprotease
DE3889665T2 (de) Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.
PT783693E (pt) Modelos in vitro da funcao e da disfuncao do snc
ATE243532T1 (de) Verfahren zur bewertung von chemotherapeutischen mitteln in vivo
SE9403833D0 (sv) Analysförfarande och kit
DE69026024D1 (de) Künstlicher Träger zur Immobilisierung von biologischen Proteinen und Verfahren zu seiner Herstellung
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
DE69704279D1 (de) Verfahren zur detektion und/oder quantitativen bestimmung von einem gliotoxischen faktor
DE69714775T2 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
DE69618630D1 (de) Methode zur in vitro-bestimmung der bioaktivität von erythropoietin
ATE445021T1 (de) Reduktion von kreuzkontaminationen bei nukleinsäureamplifikationen
Geering The influence of the fungicide merthiolate on insect esterases in disc electrophoresis
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
DE69918132D1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
DE50115097D1 (de) Elektrochemisches Verfahren zur Bestimmung der Zellzahl und Aktivität von biologischen Systemen
HK1032246A1 (en) Method for quantifying tgf-beta.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN